RHYTHM PHARMACEUTICALS, INC. (RYTM) Interest Expense USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
  • Rhythm Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.76 M, a 55.3% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $15.6 M.
  • Rhythm Pharmaceuticals, Inc. annual Interest Expense for 2023 was $13.9 M, a 167% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $15.6 M $4.76 M +$1.69 M +55.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13.9 M $4.38 M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $3.15 M +$1.01 M +46.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $3.3 M +$3.26 M +7080% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $3.06 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q3 2022 $2.14 M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $46 K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.